查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1820094

表觀遺傳學市場報告（按產品、技術、應用和地區）2025-2033

Epigenetics Market Report by Product, Technology, Application, and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 146 Pages | 商品交期: 2-3個工作天內

價格

2024 年全球表觀遺傳學市場規模達 27 億美元。展望未來， IMARC Group預計到 2033 年市場規模將達到 78 億美元，2025-2033 年期間的成長率 (CAGR) 為 12.02%。

表觀遺傳學是指研究活性和非活性基因表現中可遺傳的變化。變化的來源可以是外部環境因素，也可以是內部因素，例如年齡和疾病。它通常用於診斷潛在疾病並防止其遺傳給後代。它涉及各種酵素、儀器（例如測序儀、光譜儀和超音波儀）、試劑和試劑盒的使用。它們通常用於去氧核糖核酸 (DNA) 和組蛋白甲基化、非編碼核糖核酸 (RNA)、乙醯化和磷酸化。因此，表觀遺傳學廣泛應用於腫瘤、自體免疫、代謝、心血管和疼痛疾病的診斷、監測和治療。

表觀遺傳學市場趨勢：

全球癌症和自體免疫缺陷症候群（愛滋病）的日益普及是推動市場成長的關鍵因素之一。此外，表觀遺傳學解決方案在非腫瘤疾病治療中的廣泛應用也為市場成長提供了動力。突如其來的新冠肺炎疫情（COVID-19）也為市場參與者提供了成長機會。例如，各研究機構正在進行先進的表觀遺傳學測試，以研究病毒對人類基因組的影響，並正在開發用於早期識別、風險評估和個人化治療的工具。此外，DNA和RNA修飾酶（例如乙醯化酶、甲基轉移酶、逆轉錄酶和連接酶）的開發，以及高靈敏度和高選擇性測試和儀器的推出，也起到了其他促進成長的因素作用。這些創新有助於評估基因組中位點特異性DNA甲基化。其他因素，包括生物技術領域的廣泛研發活動，以及醫療保健基礎設施的顯著改善，尤其是在發展中經濟體，預計將推動市場成長。

本報告回答的關鍵問題

  • 全球表觀遺傳學市場有多大？ 2025-2033年全球表觀遺傳學市場的預期成長率是多少？
  • 推動全球表觀遺傳學市場發展的關鍵因素有哪些？
  • COVID-19 對全球表觀遺傳學市場有何影響？
  • 根據產品，全球表觀遺傳學市場如何分佈？
  • 根據技術，全球表觀遺傳學市場如何分佈？
  • 根據應用，全球表觀遺傳學市場如何分佈？
  • 全球表觀遺傳學市場的主要區域有哪些？
  • 全球表觀遺傳學市場的主要參與者/公司有哪些？

目錄

第1章：前言

第2章：範圍與方法

  • 研究目標
  • 利害關係人
  • 資料來源
    • 主要來源
    • 二手資料
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章：執行摘要

第4章：簡介

第5章：全球表觀遺傳學市場

  • 市場概況
  • 市場表現
  • COVID-19的影響
  • 市場預測

第6章：市場區隔：依產品

  • 試劑
  • 套件
    • 關鍵部分
      • 晶片定序試劑盒
      • 全基因組擴增試劑盒
      • 亞硫酸氫鹽轉化試劑盒
      • RNA定序試劑盒
      • 其他
  • 儀器
  • 酵素
  • 服務

第7章：市場區隔：依技術

  • DNA甲基化
  • 組蛋白甲基化
  • 組蛋白乙醯化
  • 大型非編碼RNA
  • MicroRNA修飾
  • 染色質結構

第 8 章：市場區隔：按應用

  • 腫瘤學
    • 關鍵部分
      • 實體腫瘤
      • 液體腫瘤
  • 非腫瘤學
    • 關鍵部分
      • 發炎性疾病
      • 代謝性疾病
      • 傳染病
      • 心血管疾病
      • 其他

第9章：市場細分：依地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第 10 章：SWOT 分析

第 11 章：價值鏈分析

第 12 章：波特五力分析

第13章：價格分析

第 14 章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Abcam plc
    • Active Motif Inc.
    • Agilent Technologies Inc.
    • Diagenode Diagnostics (Hologic Inc)
    • Illumina Inc.
    • Merck KGaA
    • PerkinElmer Inc.
    • Roche Holding AG
    • Thermo Fisher Scientific Inc.
    • Zymo Research Corporation
Product Code: SR112025A4096

The global epigenetics market size reached USD 2.7 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 7.8 Billion by 2033, exhibiting a growth rate (CAGR) of 12.02% during 2025-2033.

Epigenetics refers to the study of heritable changes in the expression of active and inactive genes. The sources of changes can be both external from environmental factors or internal factors, such as age and disease. It is commonly used for the diagnosis of underlying conditions and preventing them from getting transferred to the future generations. It involves the use of various enzymes, instruments, such as sequencers, spectrometers and sonicators, reagents and kits. They are commonly utilized for deoxyribonucleic acid (DNA) and histone methylation, non-coding ribonucleic acid (RNA), acetylation and phosphorylation. As a result, epigenetics is widely used for the diagnosis, monitoring and treatment of oncological, autoimmune, metabolic, cardiovascular and pain disorders.

Epigenetics Market Trends:

The increasing prevalence of cancer and autoimmune deficiency syndrome (AIDS) across the globe is among the key factors driving the market growth. Moreover, the widespread adoption of epigenetic solutions for non-oncological ailments is providing a thrust to the market growth. The sudden outbreak of the coronavirus disease (COVID-19) is also providing growth opportunities to market players. For instance, various research institutes are running advanced epigenetic tests to study the impact of the virus on the human genome and are developing tools for early recognition, risk evaluations and developing personalized treatments. Additionally, the development of DNA and RNA modifying enzymes, such as acetylases, methyltransferases, reverse transcriptase and ligases, and the launch of highly sensitive and selective tests and instruments, are acting as other growth-inducing factors. These innovations facilitate the assessment of locus-specific DNA methylation on a genome. Other factors, including extensive research and development (R&D) activities in the field of biotechnology, along with significant improvements in the healthcare infrastructure, especially in the developing economies, are anticipated to drive the market toward growth.

Key Market Segmentation:

Breakup by Product:

  • Reagents
  • Kits
    • Chip Sequencing Kit
    • Whole Genomic Amplification Kit
    • Bisulfite Conversion Kit
    • RNA Sequencing Kit
    • Others
  • Instruments
  • Enzymes
  • Services

Breakup by Technology:

  • DNA Methylation
  • Histone Methylation
  • Histone Acetylation
  • Large Non-Coding RNA
  • MicroRNA Modification
  • Chromatin Structures

Breakup by Application:

  • Oncology
    • Solid Tumors
    • Liquid Tumors
  • Non-Oncology
    • Inflammatory Diseases
    • Metabolic Diseases
    • Infectious Diseases
    • Cardiovascular Diseases
    • Others

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abcam plc, Active Motif Inc., Agilent Technologies Inc., Diagenode Diagnostics (Hologic Inc), Illumina Inc., Merck KGaA, PerkinElmer Inc., Roche Holding AG, Thermo Fisher Scientific Inc. and Zymo Research Corporation.

Key Questions Answered in This Report

  • 1.How big is the global epigenetics market?
  • 2.What is the expected growth rate of the global epigenetics market during 2025-2033?
  • 3.What are the key factors driving the global epigenetics market?
  • 4.What has been the impact of COVID-19 on the global epigenetics market?
  • 5.What is the breakup of the global epigenetics market based on the product?
  • 6.What is the breakup of the global epigenetics market based on the technology?
  • 7.What is the breakup of the global epigenetics market based on the application?
  • 8.What are the key regions in the global epigenetics market?
  • 9.Who are the key players/companies in the global epigenetics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Epigenetics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Reagents
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Kits
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Chip Sequencing Kit
      • 6.2.2.2 Whole Genomic Amplification Kit
      • 6.2.2.3 Bisulfite Conversion Kit
      • 6.2.2.4 RNA Sequencing Kit
      • 6.2.2.5 Others
    • 6.2.3 Market Forecast
  • 6.3 Instruments
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Enzymes
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Services
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by Technology

  • 7.1 DNA Methylation
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Histone Methylation
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Histone Acetylation
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Large Non-Coding RNA
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 MicroRNA Modification
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Chromatin Structures
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Oncology
    • 8.1.1 Market Trends
    • 8.1.2 Key Segments
      • 8.1.2.1 Solid Tumors
      • 8.1.2.2 Liquid Tumors
    • 8.1.3 Market Forecast
  • 8.2 Non-Oncology
    • 8.2.1 Market Trends
    • 8.2.2 Key Segments
      • 8.2.2.1 Inflammatory Diseases
      • 8.2.2.2 Metabolic Diseases
      • 8.2.2.3 Infectious Diseases
      • 8.2.2.4 Cardiovascular Diseases
      • 8.2.2.5 Others
    • 8.2.3 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abcam plc
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Active Motif Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Agilent Technologies Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Diagenode Diagnostics (Hologic Inc)
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 Illumina Inc.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Merck KGaA
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 PerkinElmer Inc.
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Roche Holding AG
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
    • 14.3.9 Thermo Fisher Scientific Inc.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Zymo Research Corporation
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio

List of Figures

  • Figure 1: Global: Epigenetics Market: Major Drivers and Challenges
  • Figure 2: Global: Epigenetics Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Epigenetics Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Epigenetics Market: Breakup by Product (in %), 2024
  • Figure 5: Global: Epigenetics Market: Breakup by Technology (in %), 2024
  • Figure 6: Global: Epigenetics Market: Breakup by Application (in %), 2024
  • Figure 7: Global: Epigenetics Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Epigenetics (Reagents) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Epigenetics (Reagents) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Epigenetics (Kits) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Epigenetics (Kits) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Epigenetics (Instruments) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Epigenetics (Instruments) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Epigenetics (Enzymes) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Epigenetics (Enzymes) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Epigenetics (Services) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Epigenetics (Services) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Epigenetics (DNA Methylation) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Epigenetics (DNA Methylation) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Epigenetics (Histone Methylation) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Epigenetics (Histone Methylation) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Epigenetics (Histone Acetylation) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Epigenetics (Histone Acetylation) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Epigenetics (Large Non-Coding RNA) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Epigenetics (Large Non-Coding RNA) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Global: Epigenetics (MicroRNA Modification) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Global: Epigenetics (MicroRNA Modification) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: Global: Epigenetics (Chromatin Structures) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: Global: Epigenetics (Chromatin Structures) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: Global: Epigenetics (Oncology) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: Global: Epigenetics (Oncology) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: Global: Epigenetics (Non-Oncology) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: Global: Epigenetics (Non-Oncology) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: North America: Epigenetics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: North America: Epigenetics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: United States: Epigenetics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: United States: Epigenetics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: Canada: Epigenetics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: Canada: Epigenetics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: Asia-Pacific: Epigenetics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: Asia-Pacific: Epigenetics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: China: Epigenetics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: China: Epigenetics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: Japan: Epigenetics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: Japan: Epigenetics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: India: Epigenetics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: India: Epigenetics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: South Korea: Epigenetics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: South Korea: Epigenetics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: Australia: Epigenetics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: Australia: Epigenetics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: Indonesia: Epigenetics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: Indonesia: Epigenetics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: Others: Epigenetics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: Others: Epigenetics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: Europe: Epigenetics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: Europe: Epigenetics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: Germany: Epigenetics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: Germany: Epigenetics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: France: Epigenetics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: France: Epigenetics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: United Kingdom: Epigenetics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: United Kingdom: Epigenetics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Italy: Epigenetics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Italy: Epigenetics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Spain: Epigenetics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Spain: Epigenetics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Russia: Epigenetics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Russia: Epigenetics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Others: Epigenetics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Others: Epigenetics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Latin America: Epigenetics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Latin America: Epigenetics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 74: Brazil: Epigenetics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 75: Brazil: Epigenetics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 76: Mexico: Epigenetics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 77: Mexico: Epigenetics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 78: Others: Epigenetics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 79: Others: Epigenetics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 80: Middle East and Africa: Epigenetics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 81: Middle East and Africa: Epigenetics Market: Breakup by Country (in %), 2024
  • Figure 82: Middle East and Africa: Epigenetics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 83: Global: Epigenetics Industry: SWOT Analysis
  • Figure 84: Global: Epigenetics Industry: Value Chain Analysis
  • Figure 85: Global: Epigenetics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Epigenetics Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Epigenetics Market Forecast: Breakup by Product (in Million USD), 2025-2033
  • Table 3: Global: Epigenetics Market Forecast: Breakup by Technology (in Million USD), 2025-2033
  • Table 4: Global: Epigenetics Market Forecast: Breakup by Application (in Million USD), 2025-2033
  • Table 5: Global: Epigenetics Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Epigenetics Market: Competitive Structure
  • Table 7: Global: Epigenetics Market: Key Players